AtriCure Inc.
Last updated September 27, 2026
Organization details
- Legal name
- AtriCure Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ATRC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001323885
Board of directors
-
B. Kristine Johnson · DirectorSince 2023
-
Deborah H. Telman · DirectorSince 2023
-
Karen Prange · DirectorSince 2023
-
Maggie Yuen · DirectorSince 2023
-
Mark A. Collar · DirectorSince 2023
-
Michael H. Carrel · Director · President, CEO, & DirectorSince 2023
-
Regina E. Groves · DirectorSince 2023
-
Robert S. White · DirectorSince 2023
-
Shlomo Nachman · DirectorSince 2024
-
Sven Wehrwein · DirectorSince 2023
Chief executives
Michael H. Carrel
· President, CEO, & Director
Dates unknown
Board connections
5 of this board's directors also sit on 7 other boards.
- via B. Kristine Johnson
- via Karen Prange
- via Regina E. Groves
- via Michael H. Carrel
- via Karen Prange
- via Sven Wehrwein
- via Sven Wehrwein
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $4,370,025
- 17 sales by 8 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 23, 2026 | Privitera Salvatore Officer (Chief Technical Officer) | Open-market sale | −4,519 | $60.00 | $271,140 |
| Sep 11, 2026 | Regina E. Groves Director | Open-market sale | −5,313 | $54.22 | $288,071 |
| Sep 8, 2026 | Privitera Salvatore Officer (Chief Technical Officer) | Open-market sale | −3,657 | $55.00 | $201,135 |
| Sep 2, 2026 | Privitera Salvatore Officer (Chief Technical Officer) | Open-market sale | −7,763 | $52.50 | $407,558 |
| Aug 24, 2026 | Dahlquist Karl S. Officer (Chief Legal Officer) | Open-market sale | −9,370 | $48.89 | $458,099 |
| Aug 5, 2026 | Karen Prange Director | Open-market sale | −3,564 | $38.80 | $138,283 |
| Aug 5, 2026 | Maggie Yuen Director | Open-market sale | −3,500 | $38.42 | $134,470 |
| Jul 30, 2026 | Michael H. Carrel Director, Officer (President, CEO, & Director) | Gift | −700 | — | — |
| Jul 30, 2026 | Michael H. Carrel Director, Officer (President, CEO, & Director) | Gift | −4,000 | — | — |
| Jul 29, 2026 | Noznesky Justin J Officer (Chief Mktg & Strategy Officer) | Open-market sale | −6,182 | $38.80 | $239,862 |
| Jul 28, 2026 | Sven Wehrwein Director | Option exercise | +25,000 | $19.95 | $498,750 |
| Jul 28, 2026 | Doraiswamy Vinayak Officer (Chief Scientific Officer) | Open-market sale | −6,000 | $38.88 | $233,280 |
| Jul 28, 2026 | Sven Wehrwein Director | Open-market sale | −25,000 | $37.84 | $946,000 |
| Jun 30, 2026 | Michael H. Carrel Director, Officer (President, CEO, & Director) | Grant or award | +636 | $23.78 | $15,124 |
| Jun 30, 2026 | Privitera Salvatore Officer (Chief Technical Officer) | Grant or award | +636 | $23.78 | $15,124 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.